Jeffrey Jerome Ludwig is CCO at PUMA BIOTECHNOLOGY, INC. (PBYI). They have made 3 open-market trades across 1 company since 2022, most recently 2025-02-07.
CIK 0001807133
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PBYI | 156,792 | $1.7M |
Shares reported on the most recent Form 4, priced at the 2025-02-11 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PBYI | SELL · 10b5-1 | 2025-01-02 | 2025-01-03 | $3.15 | $30K | -5.9% | -13.1% | -9.0% |
| PBYI | SELL · 10b5-1 | 2024-07-17 | 2024-07-18 | $3.70 | $10K | -2.2% | -23.5% | -22.2% |
| PBYI | SELL · 10b5-1 | 2024-07-02 | 2024-07-02 | $3.27 | $20K | +18.8% | +13.6% | -17.2% |
| PBYI | SELL · 10b5-1 | 2024-01-03 | 2024-01-05 | $4.49 | $116K | +7.3% | +2.3% | +15.5% |
| PBYI | SELL · 10b5-1 | 2023-07-03 | 2023-07-06 | $3.31 | $40K | +7.8% | +28.3% | -19.9% |
| PBYI | SELL | 2023-01-03 | 2023-01-05 | $4.18 | $27K | -5.2% | -2.8% | -40.6% |
| PBYI | SELL | 2022-07-05 | 2022-07-07 | $2.63 | $15K | +17.9% | +24.6% | -12.9% |
| PBYI | SELL | 2022-01-03 | 2022-01-05 | $3.20 | $15K | -14.3% | -17.7% | +12.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.